Skip to main content
Erschienen in: General Thoracic and Cardiovascular Surgery 5/2024

14.03.2024 | Review Article

Heritable thoracic aortic disease: a literature review on genetic aortopathies and current surgical management

verfasst von: Alexander C. Mills, Harleen K. Sandhu, Yuki Ikeno, Akiko Tanaka

Erschienen in: General Thoracic and Cardiovascular Surgery | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Heritable thoracic aortic disease puts patients at risk for aortic aneurysms, rupture, and dissections. The diagnosis and management of this heterogenous patient population continues to evolve. Last year, the American Heart Association/American College of Cardiology Joint Committee published diagnosis and management guidelines for aortic disease, which included those with genetic aortopathies. Additionally, evolving research studying the implications of underlying genetic aberrations with new genetic testing continues to become available. In this review, we evaluate the current literature surrounding the diagnosis and management of heritable thoracic aortic disease, as well as novel therapeutic approaches and future directions of research.
Literatur
1.
Zurück zum Zitat Sampson UK, Norman PE, Fowkes FG, Aboyans V, Song Y, Harrell F Jr, et al. Global and regional burden of aortic dissection and aneurysms: mortality trends in 21 world regions, 1990 to 2010. Glob Heart. 2014;9(1):171–80.PubMedCrossRef Sampson UK, Norman PE, Fowkes FG, Aboyans V, Song Y, Harrell F Jr, et al. Global and regional burden of aortic dissection and aneurysms: mortality trends in 21 world regions, 1990 to 2010. Glob Heart. 2014;9(1):171–80.PubMedCrossRef
2.
Zurück zum Zitat McClure RS, Brogly SB, Lajkosz K, Payne D, Hall SF, Johnson AP. Epidemiology and management of thoracic aortic dissections and thoracic aortic aneurysms in Ontario, Canada: a population-based study. J Thorac Cardiovasc Surg. 2018;155(6):2254-2264.e4.PubMedCrossRef McClure RS, Brogly SB, Lajkosz K, Payne D, Hall SF, Johnson AP. Epidemiology and management of thoracic aortic dissections and thoracic aortic aneurysms in Ontario, Canada: a population-based study. J Thorac Cardiovasc Surg. 2018;155(6):2254-2264.e4.PubMedCrossRef
3.
Zurück zum Zitat Centers for Disease Control and Prevention, National Center for Health Statistics. About Multiple Cause of Death, 1999–2019. CDC WONDER Online Database website. Atlanta, GA: Centers for Disease Control and Prevention; 2019. Accessed 15 Aug 2023. Centers for Disease Control and Prevention, National Center for Health Statistics. About Multiple Cause of Death, 1999–2019. CDC WONDER Online Database website. Atlanta, GA: Centers for Disease Control and Prevention; 2019. Accessed 15 Aug 2023.
4.
Zurück zum Zitat Elbadawi A, Elgendy IY, Jimenez E, Omer MA, Shahin HI, Ogunbayo GO, et al. Trends and outcomes of elective thoracic aortic repair and acute thoracic aortic syndromes in the United States. Am J Med. 2021;134(7):902-909.e5.PubMedCrossRef Elbadawi A, Elgendy IY, Jimenez E, Omer MA, Shahin HI, Ogunbayo GO, et al. Trends and outcomes of elective thoracic aortic repair and acute thoracic aortic syndromes in the United States. Am J Med. 2021;134(7):902-909.e5.PubMedCrossRef
5.
Zurück zum Zitat Elbadawi A, Mahmoud AA, Mahmoud K, Elgendy IY, Omer MA, Elsherbeny A, et al. Temporal trends and outcomes of elective thoracic aortic repair and acute aortic syndromes in bicuspid aortic valves: insights from a national database. Cardiol Ther. 2021;10(2):531–45.PubMedPubMedCentralCrossRef Elbadawi A, Mahmoud AA, Mahmoud K, Elgendy IY, Omer MA, Elsherbeny A, et al. Temporal trends and outcomes of elective thoracic aortic repair and acute aortic syndromes in bicuspid aortic valves: insights from a national database. Cardiol Ther. 2021;10(2):531–45.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Jayarajan SN, Vlada CA, Sanchez LA, Jim J. National temporal trends and determinants of cost of abdominal aortic aneurysm repair. Vascular. 2020;28(6):697–704.PubMedCrossRef Jayarajan SN, Vlada CA, Sanchez LA, Jim J. National temporal trends and determinants of cost of abdominal aortic aneurysm repair. Vascular. 2020;28(6):697–704.PubMedCrossRef
9.
Zurück zum Zitat Albornoz G, Coady MA, Roberts M, Davies RR, Tranquilli M, Rizzo JA, et al. Familial thoracic aortic aneurysms and dissections–incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg. 2006;82(4):1400–5.PubMedCrossRef Albornoz G, Coady MA, Roberts M, Davies RR, Tranquilli M, Rizzo JA, et al. Familial thoracic aortic aneurysms and dissections–incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg. 2006;82(4):1400–5.PubMedCrossRef
10.
Zurück zum Zitat Coady MA, Davies RR, Roberts M, Goldstein LJ, Rogalski MJ, Rizzo JA, et al. Familial patterns of thoracic aortic aneurysms. Arch Surg. 1999;134(4):361–7.PubMedCrossRef Coady MA, Davies RR, Roberts M, Goldstein LJ, Rogalski MJ, Rizzo JA, et al. Familial patterns of thoracic aortic aneurysms. Arch Surg. 1999;134(4):361–7.PubMedCrossRef
11.
Zurück zum Zitat Braverman AC, Schermerhorn M. Braunwald’s Heart disease: a textbook of cardiovascular medicine. 11th ed. Amsterdam: Elsevier; 2018. Braverman AC, Schermerhorn M. Braunwald’s Heart disease: a textbook of cardiovascular medicine. 11th ed. Amsterdam: Elsevier; 2018.
12.
13.
Zurück zum Zitat Bossone E, LaBounty TM, Eagle KA. Acute aortic syndromes: diagnosis and management, an update. Eur Heart J. 2018;39(9):739–749d.PubMedCrossRef Bossone E, LaBounty TM, Eagle KA. Acute aortic syndromes: diagnosis and management, an update. Eur Heart J. 2018;39(9):739–749d.PubMedCrossRef
14.
Zurück zum Zitat Bossone E, Eagle KA. Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes. Nat Rev Cardiol. 2021;18(5):331–48.PubMedCrossRef Bossone E, Eagle KA. Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes. Nat Rev Cardiol. 2021;18(5):331–48.PubMedCrossRef
15.
Zurück zum Zitat Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, et al. The international registry of acute aortic dissection (IRAD): new insights into an old disease. JAMA. 2000;283(7):897–903.PubMedCrossRef Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, et al. The international registry of acute aortic dissection (IRAD): new insights into an old disease. JAMA. 2000;283(7):897–903.PubMedCrossRef
16.
17.
Zurück zum Zitat Goyal A, Keramati AR, Czarny MJ, Resar JR, Mani A. The genetics of aortopathies in clinical cardiology. Clin Med Insights Cardiol. 2017;30(11):1179546817709787. Goyal A, Keramati AR, Czarny MJ, Resar JR, Mani A. The genetics of aortopathies in clinical cardiology. Clin Med Insights Cardiol. 2017;30(11):1179546817709787.
18.
Zurück zum Zitat Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006;355(8):788–98.PubMedCrossRef Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006;355(8):788–98.PubMedCrossRef
19.
Zurück zum Zitat De Backer J, Jondeau G, Boileau C. Genetic testing for aortopathies: primer for the nongeneticist. Curr Opin Cardiol. 2019;34(6):585–93.PubMedCrossRef De Backer J, Jondeau G, Boileau C. Genetic testing for aortopathies: primer for the nongeneticist. Curr Opin Cardiol. 2019;34(6):585–93.PubMedCrossRef
20.
Zurück zum Zitat Isselbacher EM, Preventza O, Hamilton Black J III, Augoustides JG, Beck AW, Bolen MA, et al. 2022 ACC/AHA Guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022;146(24):e334–482.PubMedCrossRef Isselbacher EM, Preventza O, Hamilton Black J III, Augoustides JG, Beck AW, Bolen MA, et al. 2022 ACC/AHA Guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022;146(24):e334–482.PubMedCrossRef
21.
Zurück zum Zitat Demo E, Rigelsky C, Rideout AL, Graf M, Pariani M, Regalado E, MacCarrick G. Genetics and precision medicine: heritable thoracic aortic disease. Med Clin North Am. 2019;103(6):1005–19.PubMedCrossRef Demo E, Rigelsky C, Rideout AL, Graf M, Pariani M, Regalado E, MacCarrick G. Genetics and precision medicine: heritable thoracic aortic disease. Med Clin North Am. 2019;103(6):1005–19.PubMedCrossRef
22.
Zurück zum Zitat Thakker PD, Braverman AC. Cardiogenetics: genetic testing in the diagnosis and management of patients with aortic disease. Heart. 2021;107(8):619–26.PubMedCrossRef Thakker PD, Braverman AC. Cardiogenetics: genetic testing in the diagnosis and management of patients with aortic disease. Heart. 2021;107(8):619–26.PubMedCrossRef
23.
Zurück zum Zitat Raunsø J, Song RJ, Vasan RS, Bourdillon MT, Nørager B, Torp-Pedersen C, et al. Familial clustering of aortic size, aneurysms, and dissections in the community. Circulation. 2020;142(10):920–8.PubMedCrossRef Raunsø J, Song RJ, Vasan RS, Bourdillon MT, Nørager B, Torp-Pedersen C, et al. Familial clustering of aortic size, aneurysms, and dissections in the community. Circulation. 2020;142(10):920–8.PubMedCrossRef
24.
Zurück zum Zitat Faggion Vinholo T, Brownstein AJ, Ziganshin BA, Zafar MA, Kuivaniemi H, Body SC, et al. Genes associated with thoracic aortic aneurysm and dissection: 2019 update and clinical implications. Aorta (Stamford). 2019;7(4):99–107.PubMedCrossRef Faggion Vinholo T, Brownstein AJ, Ziganshin BA, Zafar MA, Kuivaniemi H, Body SC, et al. Genes associated with thoracic aortic aneurysm and dissection: 2019 update and clinical implications. Aorta (Stamford). 2019;7(4):99–107.PubMedCrossRef
25.
Zurück zum Zitat Klarin D, Devineni P, Sendamarai AK, Angueira AR, Graham SE, Shen YH, et al. Genome-wide association study of thoracic aortic aneurysm and dissection in the Million Veteran Program. Nat Genet. 2023;55(7):1106–15.PubMedPubMedCentralCrossRef Klarin D, Devineni P, Sendamarai AK, Angueira AR, Graham SE, Shen YH, et al. Genome-wide association study of thoracic aortic aneurysm and dissection in the Million Veteran Program. Nat Genet. 2023;55(7):1106–15.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat McKUSICK VA. The cardiovascular aspects of Marfan’s syndrome: a heritable disorder of connective tissue. Circulation. 1955;11(3):321–42.PubMedCrossRef McKUSICK VA. The cardiovascular aspects of Marfan’s syndrome: a heritable disorder of connective tissue. Circulation. 1955;11(3):321–42.PubMedCrossRef
28.
Zurück zum Zitat Mellody KT, Freeman LJ, Baldock C, Jowitt TA, Siegler V, Raynal BD, et al. Marfan syndrome-causing mutations in fibrillin-1 result in gross morphological alterations and highlight the structural importance of the second hybrid domain. J Biol Chem. 2006;281(42):31854–62.PubMedCrossRef Mellody KT, Freeman LJ, Baldock C, Jowitt TA, Siegler V, Raynal BD, et al. Marfan syndrome-causing mutations in fibrillin-1 result in gross morphological alterations and highlight the structural importance of the second hybrid domain. J Biol Chem. 2006;281(42):31854–62.PubMedCrossRef
29.
Zurück zum Zitat Chaudhry SS, Cain SA, Morgan A, Dallas SL, Shuttleworth CA, Kielty CM. Fibrillin-1 regulates the bioavailability of TGFbeta1. J Cell Biol. 2007;176(3):355–67.PubMedPubMedCentralCrossRef Chaudhry SS, Cain SA, Morgan A, Dallas SL, Shuttleworth CA, Kielty CM. Fibrillin-1 regulates the bioavailability of TGFbeta1. J Cell Biol. 2007;176(3):355–67.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis. 2007;19(2):32.CrossRef Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis. 2007;19(2):32.CrossRef
31.
32.
Zurück zum Zitat Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005;37(3):275–81.PubMedCrossRef Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005;37(3):275–81.PubMedCrossRef
33.
Zurück zum Zitat Velchev JD, Van Laer L, Luyckx I, Dietz H, Loeys B. Loeys-Dietz syndrome. Adv Exp Med Biol. 2021;1348:251–64.PubMedCrossRef Velchev JD, Van Laer L, Luyckx I, Dietz H, Loeys B. Loeys-Dietz syndrome. Adv Exp Med Biol. 2021;1348:251–64.PubMedCrossRef
34.
Zurück zum Zitat Greally MT. Shprintzen-Goldberg Syndrome. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. 2006 Jan 13 [updated 2020 Apr 9]. Greally MT. Shprintzen-Goldberg Syndrome. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. 2006 Jan 13 [updated 2020 Apr 9].
35.
Zurück zum Zitat Doyle AJ, Doyle JJ, Bessling SL, Maragh S, Lindsay ME, Schepers D, et al. Mutations in the TGF-β repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat Genet. 2012;44(11):1249–54.PubMedPubMedCentralCrossRef Doyle AJ, Doyle JJ, Bessling SL, Maragh S, Lindsay ME, Schepers D, et al. Mutations in the TGF-β repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat Genet. 2012;44(11):1249–54.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Billon C, Adham S, Hernandez Poblete N, Legrand A, Frank M, Chiche L, et al. Cardiovascular and connective tissue disorder features in FLNA-related PVNH patients: progress towards a refined delineation of this syndrome. Orphanet J Rare Dis. 2021;16(1):504.PubMedPubMedCentralCrossRef Billon C, Adham S, Hernandez Poblete N, Legrand A, Frank M, Chiche L, et al. Cardiovascular and connective tissue disorder features in FLNA-related PVNH patients: progress towards a refined delineation of this syndrome. Orphanet J Rare Dis. 2021;16(1):504.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Meester JAN, De Kinderen P, Verstraeten A, Loeys B. Meester-Loeys syndrome. Adv Exp Med Biol. 2021;1348:265–72.PubMedCrossRef Meester JAN, De Kinderen P, Verstraeten A, Loeys B. Meester-Loeys syndrome. Adv Exp Med Biol. 2021;1348:265–72.PubMedCrossRef
38.
Zurück zum Zitat Van Gucht I, Krebsova A, Diness BR, Laga S, Adlam D, Kempers M, et al. Novel LOX variants in five families with aortic/arterial aneurysm and dissection with variable connective tissue findings. Int J Mol Sci. 2021;22(13):7111.PubMedPubMedCentralCrossRef Van Gucht I, Krebsova A, Diness BR, Laga S, Adlam D, Kempers M, et al. Novel LOX variants in five families with aortic/arterial aneurysm and dissection with variable connective tissue findings. Int J Mol Sci. 2021;22(13):7111.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Milewicz DM, Østergaard JR, Ala-Kokko LM, Khan N, Grange DK, Mendoza-Londono R, et al. De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am J Med Genet A. 2010;152A(10):2437–43.PubMedPubMedCentralCrossRef Milewicz DM, Østergaard JR, Ala-Kokko LM, Khan N, Grange DK, Mendoza-Londono R, et al. De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am J Med Genet A. 2010;152A(10):2437–43.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Callewaert B, De Paepe A, Coucke P. Arterial Tortuosity Syndrome. 2014 Nov 13 [updated 2023 Feb 23]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. Callewaert B, De Paepe A, Coucke P. Arterial Tortuosity Syndrome. 2014 Nov 13 [updated 2023 Feb 23]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023.
41.
Zurück zum Zitat Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, et al. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet. 2006;38(4):452–7.PubMedCrossRef Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, et al. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet. 2006;38(4):452–7.PubMedCrossRef
42.
Zurück zum Zitat Rappold GA, Fukami M, Niesler B, Schiller S, Zumkeller W, Bettendorf M, Heinrich U, et al. Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature. J Clin Endocrinol Metab. 2002;87(3):1402–6.PubMedCrossRef Rappold GA, Fukami M, Niesler B, Schiller S, Zumkeller W, Bettendorf M, Heinrich U, et al. Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature. J Clin Endocrinol Metab. 2002;87(3):1402–6.PubMedCrossRef
43.
Zurück zum Zitat Corbitt H, Morris SA, Gravholt CH, Mortensen KH, Tippner-Hedges R, Silberbach M, et al. TIMP3 and TIMP1 are risk genes for bicuspid aortic valve and aortopathy in Turner syndrome. PLoS Genet. 2018;14(10): e1007692.PubMedPubMedCentralCrossRef Corbitt H, Morris SA, Gravholt CH, Mortensen KH, Tippner-Hedges R, Silberbach M, et al. TIMP3 and TIMP1 are risk genes for bicuspid aortic valve and aortopathy in Turner syndrome. PLoS Genet. 2018;14(10): e1007692.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Pomianowski P, Elefteriades JA. The genetics and genomics of thoracic aortic disease. Ann Cardiothorac Surg. 2013;2(3):271–9.PubMedPubMedCentral Pomianowski P, Elefteriades JA. The genetics and genomics of thoracic aortic disease. Ann Cardiothorac Surg. 2013;2(3):271–9.PubMedPubMedCentral
45.
Zurück zum Zitat Humphrey JD, Schwartz MA, Tellides G, Milewicz DM. Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections. Circ Res. 2015;116(8):1448–61.PubMedPubMedCentralCrossRef Humphrey JD, Schwartz MA, Tellides G, Milewicz DM. Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections. Circ Res. 2015;116(8):1448–61.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Martin-Blazquez A, Heredero A, Aldamiz-Echevarria G, Martin-Lorenzo M, Alvarez-Llamas G. Non-syndromic thoracic aortic aneurysm: cellular and molecular insights. J Pathol. 2021;254(3):229–38.PubMedPubMedCentralCrossRef Martin-Blazquez A, Heredero A, Aldamiz-Echevarria G, Martin-Lorenzo M, Alvarez-Llamas G. Non-syndromic thoracic aortic aneurysm: cellular and molecular insights. J Pathol. 2021;254(3):229–38.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet. 2007;39(12):1488–93.PubMedCrossRef Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet. 2007;39(12):1488–93.PubMedCrossRef
48.
Zurück zum Zitat Wang L, Guo DC, Cao J, Gong L, Kamm KE, Regalado E, Li L, et al. Mutations in myosin light chain kinase cause familial aortic dissections. Am J Hum Genet. 2010;87(5):701–7.PubMedPubMedCentralCrossRef Wang L, Guo DC, Cao J, Gong L, Kamm KE, Regalado E, Li L, et al. Mutations in myosin light chain kinase cause familial aortic dissections. Am J Hum Genet. 2010;87(5):701–7.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Glancy DL, Wegmann M, Dhurandhar RW. Aortic dissection and patent ductus arteriosus in three generations. Am J Cardiol. 2001;87(6):813–5.PubMedCrossRef Glancy DL, Wegmann M, Dhurandhar RW. Aortic dissection and patent ductus arteriosus in three generations. Am J Cardiol. 2001;87(6):813–5.PubMedCrossRef
50.
Zurück zum Zitat Zhu L, Vranckx R, Van Kien PK, Lalande A, Boisset N, Mathieu F, et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet. 2006;38(3):343–9.PubMedCrossRef Zhu L, Vranckx R, Van Kien PK, Lalande A, Boisset N, Mathieu F, et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet. 2006;38(3):343–9.PubMedCrossRef
51.
Zurück zum Zitat Guo DC, Regalado E, Casteel DE, Santos-Cortez RL, Gong L, Kim JJ, et al. Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. Am J Hum Genet. 2013;93(2):398–404.PubMedPubMedCentralCrossRef Guo DC, Regalado E, Casteel DE, Santos-Cortez RL, Gong L, Kim JJ, et al. Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. Am J Hum Genet. 2013;93(2):398–404.PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Guo DC, Gong L, Regalado ES, Santos-Cortez RL, Zhao R, Cai B, et al. MAT2A mutations predispose individuals to thoracic aortic aneurysms. Am J Hum Genet. 2015;96(1):170–7.PubMedPubMedCentralCrossRef Guo DC, Gong L, Regalado ES, Santos-Cortez RL, Zhao R, Cai B, et al. MAT2A mutations predispose individuals to thoracic aortic aneurysms. Am J Hum Genet. 2015;96(1):170–7.PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Barbier M, Gross MS, Aubart M, Hanna N, Kessler K, Guo DC, et al. MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections. Am J Hum Genet. 2014;95(6):736–43.PubMedPubMedCentralCrossRef Barbier M, Gross MS, Aubart M, Hanna N, Kessler K, Guo DC, et al. MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections. Am J Hum Genet. 2014;95(6):736–43.PubMedPubMedCentralCrossRef
54.
Zurück zum Zitat Kuang SQ, Medina-Martinez O, Guo DC, Gong L, Regalado ES, Reynolds CL, et al. FOXE3 mutations predispose to thoracic aortic aneurysms and dissections. J Clin Invest. 2016;126(3):948–61.PubMedPubMedCentralCrossRef Kuang SQ, Medina-Martinez O, Guo DC, Gong L, Regalado ES, Reynolds CL, et al. FOXE3 mutations predispose to thoracic aortic aneurysms and dissections. J Clin Invest. 2016;126(3):948–61.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Elbitar S, Renard M, Arnaud P, Hanna N, Jacob MP, Guo DC, et al. Pathogenic variants in THSD4, encoding the ADAMTS-like 6 protein, predispose to inherited thoracic aortic aneurysm. Genet Med. 2021;23(1):111–22.PubMedCrossRef Elbitar S, Renard M, Arnaud P, Hanna N, Jacob MP, Guo DC, et al. Pathogenic variants in THSD4, encoding the ADAMTS-like 6 protein, predispose to inherited thoracic aortic aneurysm. Genet Med. 2021;23(1):111–22.PubMedCrossRef
56.
Zurück zum Zitat Milewicz DM, Michael K, Fisher N, Coselli JS, Markello T, Biddinger A. Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. Circulation. 1996;94(11):2708–11.PubMedCrossRef Milewicz DM, Michael K, Fisher N, Coselli JS, Markello T, Biddinger A. Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. Circulation. 1996;94(11):2708–11.PubMedCrossRef
57.
Zurück zum Zitat Lo Presti F, Guzzardi DG, Bancone C, Fedak PWM, Della Corte A. The science of BAV aortopathy. Prog Cardiovasc Dis. 2020;63(4):465–74.PubMedCrossRef Lo Presti F, Guzzardi DG, Bancone C, Fedak PWM, Della Corte A. The science of BAV aortopathy. Prog Cardiovasc Dis. 2020;63(4):465–74.PubMedCrossRef
58.
Zurück zum Zitat Grewal N, Girdauskas E, DeRuiter M, Goumans MJ, Poelmann RE, Klautz RJM, et al. The role of hemodynamics in bicuspid aortopathy: a histopathologic study. Cardiovasc Pathol. 2019;41:29–37.PubMedCrossRef Grewal N, Girdauskas E, DeRuiter M, Goumans MJ, Poelmann RE, Klautz RJM, et al. The role of hemodynamics in bicuspid aortopathy: a histopathologic study. Cardiovasc Pathol. 2019;41:29–37.PubMedCrossRef
59.
Zurück zum Zitat Girdauskas E, Borger MA, Secknus MA, Girdauskas G, Kuntze T. Is aortopathy in bicuspid aortic valve disease a congenital defect or a result of abnormal hemodynamics? A critical reappraisal of a one-sided argument. Eur J Cardiothorac Surg. 2011;39(6):809–14.PubMedCrossRef Girdauskas E, Borger MA, Secknus MA, Girdauskas G, Kuntze T. Is aortopathy in bicuspid aortic valve disease a congenital defect or a result of abnormal hemodynamics? A critical reappraisal of a one-sided argument. Eur J Cardiothorac Surg. 2011;39(6):809–14.PubMedCrossRef
60.
Zurück zum Zitat Hope MD, Hope TA, Meadows AK, Ordovas KG, Urbania TH, Alley MT, et al. Bicuspid aortic valve: four-dimensional MR evaluation of ascending aortic systolic flow patterns. Radiology. 2010;255(1):53–61.PubMedCrossRef Hope MD, Hope TA, Meadows AK, Ordovas KG, Urbania TH, Alley MT, et al. Bicuspid aortic valve: four-dimensional MR evaluation of ascending aortic systolic flow patterns. Radiology. 2010;255(1):53–61.PubMedCrossRef
61.
Zurück zum Zitat Mozzini C, Girelli D, Cominacini L, Soresi M. An exploratory look at bicuspid aortic valve (Bav) aortopathy: focus on molecular and cellular mechanisms. Curr Probl Cardiol. 2021;46(3): 100425.PubMedCrossRef Mozzini C, Girelli D, Cominacini L, Soresi M. An exploratory look at bicuspid aortic valve (Bav) aortopathy: focus on molecular and cellular mechanisms. Curr Probl Cardiol. 2021;46(3): 100425.PubMedCrossRef
62.
Zurück zum Zitat Stock S, Mohamed SA, Sievers HH. Bicuspid aortic valve related aortopathy. Gen Thorac Cardiovasc Surg. 2019;67(1):93–101.PubMedCrossRef Stock S, Mohamed SA, Sievers HH. Bicuspid aortic valve related aortopathy. Gen Thorac Cardiovasc Surg. 2019;67(1):93–101.PubMedCrossRef
63.
Zurück zum Zitat Jiao J, Xiong W, Wang L, Yang J, Qiu P, Hirai H, et al. Differentiation defect in neural crest-derived smooth muscle cells in patients with aortopathy associated with bicuspid aortic valves. EBioMedicine. 2016;10:282–90.PubMedPubMedCentralCrossRef Jiao J, Xiong W, Wang L, Yang J, Qiu P, Hirai H, et al. Differentiation defect in neural crest-derived smooth muscle cells in patients with aortopathy associated with bicuspid aortic valves. EBioMedicine. 2016;10:282–90.PubMedPubMedCentralCrossRef
64.
Zurück zum Zitat Gould RA, Aziz H, Woods CE, Seman-Senderos MA, Sparks E, Preuss C, et al. ROBO4 variants predispose individuals to bicuspid aortic valve and thoracic aortic aneurysm. Nat Genet. 2019;51(1):42–50.PubMedCrossRef Gould RA, Aziz H, Woods CE, Seman-Senderos MA, Sparks E, Preuss C, et al. ROBO4 variants predispose individuals to bicuspid aortic valve and thoracic aortic aneurysm. Nat Genet. 2019;51(1):42–50.PubMedCrossRef
65.
Zurück zum Zitat Luyckx I, Kumar AA, Reyniers E, Dekeyser E, Vanderstraeten K, Vandeweyer G, et al. Copy number variation analysis in bicuspid aortic valve-related aortopathy identifies TBX20 as a contributing gene. Eur J Hum Genet. 2019;27(7):1033–43.PubMedPubMedCentralCrossRef Luyckx I, Kumar AA, Reyniers E, Dekeyser E, Vanderstraeten K, Vandeweyer G, et al. Copy number variation analysis in bicuspid aortic valve-related aortopathy identifies TBX20 as a contributing gene. Eur J Hum Genet. 2019;27(7):1033–43.PubMedPubMedCentralCrossRef
66.
Zurück zum Zitat Nunes R, Gouveia E, Melo R, Almeida AG, de Almeida E, Pinto FJ, Pedro LM, et al. Does autosomal dominant polycystic kidney disease increase the risk of aortic aneurysm or dissection: a point of view based on a systematic review and meta-analysis. J Nephrol. 2022;35(6):1585–93.PubMedCrossRef Nunes R, Gouveia E, Melo R, Almeida AG, de Almeida E, Pinto FJ, Pedro LM, et al. Does autosomal dominant polycystic kidney disease increase the risk of aortic aneurysm or dissection: a point of view based on a systematic review and meta-analysis. J Nephrol. 2022;35(6):1585–93.PubMedCrossRef
67.
Zurück zum Zitat Bouleti C, Flamant M, Escoubet B, Arnoult F, Milleron O, Vidal-Petiot E, et al. Risk of ascending aortic aneurysm in patients with autosomal dominant polycystic kidney disease. Am J Cardiol. 2019;123(3):482–8.PubMedCrossRef Bouleti C, Flamant M, Escoubet B, Arnoult F, Milleron O, Vidal-Petiot E, et al. Risk of ascending aortic aneurysm in patients with autosomal dominant polycystic kidney disease. Am J Cardiol. 2019;123(3):482–8.PubMedCrossRef
68.
Zurück zum Zitat Chen Y, Wang L, Xu X, Li K, Sun Y, Wang Y, et al. Genetic architecture of thoracic aortic dissection in the female population. Gene. 2023;15(887): 147727.CrossRef Chen Y, Wang L, Xu X, Li K, Sun Y, Wang Y, et al. Genetic architecture of thoracic aortic dissection in the female population. Gene. 2023;15(887): 147727.CrossRef
69.
Zurück zum Zitat Viuff M, Skakkebaek A, Nielsen MM, Chang S, Gravholt CH. epigenetics and genomics in turner syndrome. Am J Med Genet C Semin Med Genet. 2019;181(1):68–75.PubMedCrossRef Viuff M, Skakkebaek A, Nielsen MM, Chang S, Gravholt CH. epigenetics and genomics in turner syndrome. Am J Med Genet C Semin Med Genet. 2019;181(1):68–75.PubMedCrossRef
70.
Zurück zum Zitat Jeoffrey SMH, Kalyanasundaram A, Zafar MA, Ziganshin BA, Elefteriades JA. Genetic overlap of spontaneous dissection of either the thoracic aorta or the coronary arteries. Am J Cardiol. 2023;15(205):69–74.CrossRef Jeoffrey SMH, Kalyanasundaram A, Zafar MA, Ziganshin BA, Elefteriades JA. Genetic overlap of spontaneous dissection of either the thoracic aorta or the coronary arteries. Am J Cardiol. 2023;15(205):69–74.CrossRef
71.
Zurück zum Zitat Regalado ES, Guo DC, Prakash S, Bensend TA, Flynn K, Estrera AL, et al. Aortic disease presentation and outcome associated with ACTA2 mutations. Circ Cardiovasc Genet. 2015;8(3):457–64.PubMedPubMedCentralCrossRef Regalado ES, Guo DC, Prakash S, Bensend TA, Flynn K, Estrera AL, et al. Aortic disease presentation and outcome associated with ACTA2 mutations. Circ Cardiovasc Genet. 2015;8(3):457–64.PubMedPubMedCentralCrossRef
72.
Zurück zum Zitat Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47(7):476–85.PubMedCrossRef Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47(7):476–85.PubMedCrossRef
73.
Zurück zum Zitat Smith HS, McGuire AL, Wittenberg E, Lavelle TA. Family-level impact of genetic testing: integrating health economics and ethical, legal, and social implications. Per Med. 2021;18(3):209–12.PubMedPubMedCentralCrossRef Smith HS, McGuire AL, Wittenberg E, Lavelle TA. Family-level impact of genetic testing: integrating health economics and ethical, legal, and social implications. Per Med. 2021;18(3):209–12.PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat Milewicz DM, Guo D, Hostetler E, Marin I, Pinard AC, Cecchi AC. Update on the genetic risk for thoracic aortic aneurysms and acute aortic dissections: implications for clinical care. J Cardiovasc Surg (Torino). 2021;62(3):203–10.PubMed Milewicz DM, Guo D, Hostetler E, Marin I, Pinard AC, Cecchi AC. Update on the genetic risk for thoracic aortic aneurysms and acute aortic dissections: implications for clinical care. J Cardiovasc Surg (Torino). 2021;62(3):203–10.PubMed
75.
Zurück zum Zitat Harris SL, Lindsay ME. Role of clinical genetic testing in the management of aortopathies. Curr Cardiol Rep. 2021;23(2):10.PubMedCrossRef Harris SL, Lindsay ME. Role of clinical genetic testing in the management of aortopathies. Curr Cardiol Rep. 2021;23(2):10.PubMedCrossRef
76.
Zurück zum Zitat Hartz J, Mansfield L, de Ferranti S, Brown DW, Rhodes J. Isometric exercise increases the diameter of the ascending aorta in youth with bicuspid aortic valves. Pediatr Cardiol. 2022;43(8):1688–94.PubMedCrossRef Hartz J, Mansfield L, de Ferranti S, Brown DW, Rhodes J. Isometric exercise increases the diameter of the ascending aorta in youth with bicuspid aortic valves. Pediatr Cardiol. 2022;43(8):1688–94.PubMedCrossRef
77.
Zurück zum Zitat Dean JC. Marfan syndrome: clinical diagnosis and management. Eur J Hum Genet. 2007;15(7):724–33.PubMedCrossRef Dean JC. Marfan syndrome: clinical diagnosis and management. Eur J Hum Genet. 2007;15(7):724–33.PubMedCrossRef
78.
Zurück zum Zitat Loeys BL, Dietz HC. Loeys-Dietz syndrome. 2008 Feb 28 [updated 2018 Mar 1]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. Loeys BL, Dietz HC. Loeys-Dietz syndrome. 2008 Feb 28 [updated 2018 Mar 1]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023.
79.
Zurück zum Zitat Altobelli E, Rapacchietta L, Profeta VF, Fagnano R. Risk factors for abdominal aortic aneurysm in population-based studies: a systematic review and meta-analysis. Int J Environ Res Public Health. 2018;15(12):2805.PubMedPubMedCentralCrossRef Altobelli E, Rapacchietta L, Profeta VF, Fagnano R. Risk factors for abdominal aortic aneurysm in population-based studies: a systematic review and meta-analysis. Int J Environ Res Public Health. 2018;15(12):2805.PubMedPubMedCentralCrossRef
80.
Zurück zum Zitat Larsson SC, Mason AM, Bäck M, Klarin D, Damrauer SM, Million Veteran Program, et al. Genetic predisposition to smoking in relation to 14 cardiovascular diseases. Eur Heart J. 2020;41(35):3304–10.PubMedPubMedCentralCrossRef Larsson SC, Mason AM, Bäck M, Klarin D, Damrauer SM, Million Veteran Program, et al. Genetic predisposition to smoking in relation to 14 cardiovascular diseases. Eur Heart J. 2020;41(35):3304–10.PubMedPubMedCentralCrossRef
81.
Zurück zum Zitat Griepp RB, Ergin MA, Galla JD, Lansman SL, McCullough JN, Nguyen KH, et al. Natural history of descending thoracic and thoracoabdominal aneurysms. Ann Thorac Surg. 1999;67(6):1927–30.PubMedCrossRef Griepp RB, Ergin MA, Galla JD, Lansman SL, McCullough JN, Nguyen KH, et al. Natural history of descending thoracic and thoracoabdominal aneurysms. Ann Thorac Surg. 1999;67(6):1927–30.PubMedCrossRef
82.
Zurück zum Zitat Mullen M, Jin XY, Child A, Stuart AG, Dodd M, Aragon-Martin JA, et al. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial. Lancet. 2019;394(10216):2263–70.PubMedPubMedCentralCrossRef Mullen M, Jin XY, Child A, Stuart AG, Dodd M, Aragon-Martin JA, et al. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial. Lancet. 2019;394(10216):2263–70.PubMedPubMedCentralCrossRef
83.
Zurück zum Zitat Milleron O, Arnoult F, Ropers J, Aegerter P, Detaint D, Delorme G, et al. Marfan Sartan: a randomized, double-blind, placebo-controlled trial. Eur Heart J. 2015;36(32):2160–6.PubMedCrossRef Milleron O, Arnoult F, Ropers J, Aegerter P, Detaint D, Delorme G, et al. Marfan Sartan: a randomized, double-blind, placebo-controlled trial. Eur Heart J. 2015;36(32):2160–6.PubMedCrossRef
84.
Zurück zum Zitat Gallo EM, Loch DC, Habashi JP, Calderon JF, Chen Y, Bedja D, et al. Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest. 2014;124(1):448–60.PubMedCrossRef Gallo EM, Loch DC, Habashi JP, Calderon JF, Chen Y, Bedja D, et al. Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest. 2014;124(1):448–60.PubMedCrossRef
85.
Zurück zum Zitat Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med. 1994;330(19):1335–41.PubMedCrossRef Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med. 1994;330(19):1335–41.PubMedCrossRef
86.
Zurück zum Zitat Attenhofer Jost CH, Greutmann M, Connolly HM, Weber R, Rohrbach M, Oxenius A, et al. Medical treatment of aortic aneurysms in Marfan syndrome and other heritable conditions. Curr Cardiol Rev. 2014;10(2):161–71.PubMedCrossRef Attenhofer Jost CH, Greutmann M, Connolly HM, Weber R, Rohrbach M, Oxenius A, et al. Medical treatment of aortic aneurysms in Marfan syndrome and other heritable conditions. Curr Cardiol Rev. 2014;10(2):161–71.PubMedCrossRef
87.
Zurück zum Zitat Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, et al. ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(41):2873–926.PubMedCrossRef Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, et al. ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(41):2873–926.PubMedCrossRef
88.
Zurück zum Zitat Atkins AD, Reardon MJ, Atkins MD. Endovascular management of the ascending aorta: state of the art. Methodist DeBakey Cardiovasc J. 2023;19(2):29–37.PubMedPubMedCentralCrossRef Atkins AD, Reardon MJ, Atkins MD. Endovascular management of the ascending aorta: state of the art. Methodist DeBakey Cardiovasc J. 2023;19(2):29–37.PubMedPubMedCentralCrossRef
89.
Zurück zum Zitat Chen D, Luo M, Fang K, Shu C. Endovascular repair of acute zone 0 intramural hematoma with most proximal tear or ulcer-like projection in the descending aorta. J Vasc Surg. 2022;75(5):1561–9.PubMedCrossRef Chen D, Luo M, Fang K, Shu C. Endovascular repair of acute zone 0 intramural hematoma with most proximal tear or ulcer-like projection in the descending aorta. J Vasc Surg. 2022;75(5):1561–9.PubMedCrossRef
90.
Zurück zum Zitat Jassar AS, Sundt TM 3rd. How should we manage type A aortic dissection? Gen Thorac Cardiovasc Surg. 2019;67(1):137–45.PubMedCrossRef Jassar AS, Sundt TM 3rd. How should we manage type A aortic dissection? Gen Thorac Cardiovasc Surg. 2019;67(1):137–45.PubMedCrossRef
91.
Zurück zum Zitat Firwana M, Hasan B, Saadi S, Abd-Rabu R, Alabdallah K, Al-Zu’bi H, et al. A systematic review supporting the society for vascular surgery guidelines on the management of heritable aortopathies. J Vasc Surg. 2023;78(4):1077-1082.e12.PubMedCrossRef Firwana M, Hasan B, Saadi S, Abd-Rabu R, Alabdallah K, Al-Zu’bi H, et al. A systematic review supporting the society for vascular surgery guidelines on the management of heritable aortopathies. J Vasc Surg. 2023;78(4):1077-1082.e12.PubMedCrossRef
92.
Zurück zum Zitat Kang J, Hanif M, Mirza E, Jaleel S. Ehlers-Danlos syndrome in pregnancy: a review. Eur J Obstet Gynecol Reprod Biol. 2020;255:118–23.PubMedCrossRef Kang J, Hanif M, Mirza E, Jaleel S. Ehlers-Danlos syndrome in pregnancy: a review. Eur J Obstet Gynecol Reprod Biol. 2020;255:118–23.PubMedCrossRef
93.
Zurück zum Zitat Braverman AC, Mittauer E, Harris KM, Evangelista A, Pyeritz RE, Brinster D, et al. Clinical features and outcomes of pregnancy-related acute aortic dissection. JAMA Cardiol. 2021;6(1):58–66.PubMed Braverman AC, Mittauer E, Harris KM, Evangelista A, Pyeritz RE, Brinster D, et al. Clinical features and outcomes of pregnancy-related acute aortic dissection. JAMA Cardiol. 2021;6(1):58–66.PubMed
94.
Zurück zum Zitat Silberbach M, Roos-Hesselink JW, Andersen NH, Braverman AC, Brown N, Collins RT, et al. Cardiovascular health in turner syndrome: a scientific statement from the American Heart Association. Circ Genom Precis Med. 2018;11(10): e000048.PubMedCrossRef Silberbach M, Roos-Hesselink JW, Andersen NH, Braverman AC, Brown N, Collins RT, et al. Cardiovascular health in turner syndrome: a scientific statement from the American Heart Association. Circ Genom Precis Med. 2018;11(10): e000048.PubMedCrossRef
95.
Zurück zum Zitat Galian-Gay L, Pijuan-Domenech A, Cantalapiedra-Romero J, Serrano B, Goya M, Maiz N, et al. Pregnancy-related aortic complications in women with bicuspid aortic valve. Heart. 2023;109(15):1153–8.PubMedCrossRef Galian-Gay L, Pijuan-Domenech A, Cantalapiedra-Romero J, Serrano B, Goya M, Maiz N, et al. Pregnancy-related aortic complications in women with bicuspid aortic valve. Heart. 2023;109(15):1153–8.PubMedCrossRef
96.
Zurück zum Zitat Sawada H, Daugherty A. BEST3-mediated MEKK2/3 activation: a novel therapeutic target in aortopathies. Circulation. 2023;148(7):607–9.PubMedCrossRef Sawada H, Daugherty A. BEST3-mediated MEKK2/3 activation: a novel therapeutic target in aortopathies. Circulation. 2023;148(7):607–9.PubMedCrossRef
97.
Zurück zum Zitat Zhang TT, Lei QQ, He J, Guan X, Zhang X, Huang Y, et al. Bestrophin3 deficiency in vascular smooth muscle cells activates MEKK2/3-MAPK signaling to trigger spontaneous aortic dissection. Circulation. 2023;148(7):589–606.PubMedCrossRef Zhang TT, Lei QQ, He J, Guan X, Zhang X, Huang Y, et al. Bestrophin3 deficiency in vascular smooth muscle cells activates MEKK2/3-MAPK signaling to trigger spontaneous aortic dissection. Circulation. 2023;148(7):589–606.PubMedCrossRef
98.
Zurück zum Zitat Yang K, Ren J, Li X, Wang Z, Xue L, Cui S, et al. Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype. Eur Heart J. 2020;41(26):2442–53.PubMedCrossRef Yang K, Ren J, Li X, Wang Z, Xue L, Cui S, et al. Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype. Eur Heart J. 2020;41(26):2442–53.PubMedCrossRef
99.
Zurück zum Zitat Zhou C, Lin Z, Cao H, Chen Y, Li J, Zhuang X, et al. Anxa1 in smooth muscle cells protects against acute aortic dissection. Cardiovasc Res. 2022;118(6):1564–82.PubMedCrossRef Zhou C, Lin Z, Cao H, Chen Y, Li J, Zhuang X, et al. Anxa1 in smooth muscle cells protects against acute aortic dissection. Cardiovasc Res. 2022;118(6):1564–82.PubMedCrossRef
Metadaten
Titel
Heritable thoracic aortic disease: a literature review on genetic aortopathies and current surgical management
verfasst von
Alexander C. Mills
Harleen K. Sandhu
Yuki Ikeno
Akiko Tanaka
Publikationsdatum
14.03.2024
Verlag
Springer Nature Singapore
Erschienen in
General Thoracic and Cardiovascular Surgery / Ausgabe 5/2024
Print ISSN: 1863-6705
Elektronische ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-024-02017-x

Weitere Artikel der Ausgabe 5/2024

General Thoracic and Cardiovascular Surgery 5/2024 Zur Ausgabe

Ist die Spülung bei Bohrlochtrepanation verzichtbar?

19.06.2024 Subduralhämatom Nachrichten

Wird ein chronisches Subduralhämatom per Bohrlochtrepanation entfernt, scheint eine subdurale Ausspülung mehr Vor- als Nachteile zu haben. Das legen Ergebnisse einer finnischen Studie nahe.

Was eine zu kleine Klappe für die Langzeitprognose bedeutet

18.06.2024 Aortenklappenersatz Nachrichten

Stellt sich nach der Implantation eines biologischen Aortenklappenersatzes die Prothese als zu klein für den Patienten heraus, hat das offenbar nur geringe Auswirkungen auf Langzeitüberleben und Reoperationsrisiko; zumindest solange die effektive Öffnungsfläche über 0,65 cm2/m2 liegt.

Antibiotika nach Appendektomie: Ist kürzer besser?

18.06.2024 Appendizitis Nachrichten

Nach einer Appendektomie wegen komplizierter Appendizitis scheint eine maximal dreitägige Antibiotikabehandlung hinreichend vor Komplikationen wie intraabdominellen Abszessen und Wundinfektionen zu schützen.

TAVI bei kleinem Aortenklappenanulus: Es gibt noch ungeklärte Fragen

13.06.2024 TAVI Nachrichten

Zwischen selbstexpandierenden und ballonexpandierbaren TAVI-Klappen scheinen bezüglich der Klappenfunktion bei Aortenstenose und kleinem Aortenklappenanulus Unterschiede zu bestehen. Aber sind die überhaupt von klinischer Relevanz? Eine neue Studie liefert dazu Informationen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.